At the IGTP TODAY
Yesterday evening the ceremony to present awards to the 43 projects that will receive funding for cancer research from the 2018 edition of the La Marató de TV3 and Catalunya Radio was held at the Academy of Medical Sciences. Three of the projects will be carried out under the leadership of Germans Trias professionals.
The IGTP is one of the participating institutions working to promote this along with other research institutions and also others from academia, business and the third sector. Badalona Health Services (Badalona Serveis Assistencials, BSA), the municipal health organization promoted the candidature. BSA is part of an ecosystem of over 30 bodies and associations who make the local area eligible for the award.
The Centre for Comparative Medicine and Bioimage (CMCiB) now forms part of the Working Group on European 3Rs Centres. This literally puts it on the map, for European 3Rs Research and it has been included in the Norwegian NORECOPA website, which is currently the largest resource on European 3rs Research available. The Working Group is preparing the setting up of a European 3Rs Center Network to promote and facilitate ethical research.
On 22 August the IGTP received the HR Excellence in Research Award (HRS4R) from the European Commission (EC). The Commission's human resource strategy is aimed at aligning HR policies across European research institutions with the goal of making the movement of researchers between institutions easier and conditions fairer. The IGTP can use the HRS4R logo to identify itself as one of the 490 organizations now recognized as working towards this goal.
Two students have been awarded INPhINIT grants by “la Caixa” Foundation to complete their PhDs on the Can Ruti Campus. Emma Koehorst, has been working on Myotonic Dystrophy in the Neuromuscular and Neuropaediatric research group led by Gisela Nogales at the IGTP since last September. Ifeanyi Ezeonwumelu has started working at the IrsiCaixa on novel therapeutic strategies for HIV with Dr Ester Ballana Guix in the HIV Pathogenesis Group, led by Dr José A Esté.
This July the Government of Catalonia officially approved the Plan for Prevention and Control of Hepatitis in Catalonia, which aims to facilitate the adoption and implementation of measures to reduce the number of cases and the morbidity and mortality associated with this infection. This is in line with the goal of the WHO, which aims to eliminate hepatitis C by 2030. The plan is the result of healthcare and public health professionals, experts, representatives of scientific societies and organizations and patients and families associations all working together.
The Director of the Germans Trias I Pujol Research Institute (IGTP), Manel Puig and the Director of the Instituto de Salud Carlos III, Raquel Yotti have put their formal seal on the starting up of the Comparative Medicine and Bioimage Centre of Catalonia (CMCiB). The CMCiB is a centre built on the Can Ruti Campus by the IGTP with the aim of being a reference centre for comparative medicine, bioimaging and computational models and a pioneer in applying alternative methods for biomedical research that impacts on the health of the population. The facilities of the centre include latest generation operating theatres that are adaptable for continued training, perfecting new surgical techniques and development of new surgical devices.
Principal investigators from the nine areas of research on the Can Ruti Campus met together to discuss topics of concern in the current research environment. During the day, researchers enjoyed inputs from the IGTP research community and external speakers and were able to take advantage of the many moments available for networking and sharing.
This is the third round of evaluations the IGTP-HGTP Biobank has undertaken to ensure and certify the quality of its services. The Biorepository Proficiency Testing Program is a voluntary external evaluation programme, with members from several countries. Once again, the IGTP-HTP Biobank has been awarded the certificate, opting to apply every two years.
Manremyc, a spin-off of the IGTP specialised in the development of a probiotic against tuberculosis, has opened a funding round through Capital Cell, the first on-line investment platform in Europe specialized in biomedicine. The objective of the campaign is to reach 250,000 euros, with a minimum investment requirement per person of only 600 euros. Up to now, the company has secured 35% of the investment, which includes participation from the Reig family, main shareholders in the pharmaceutical company Reig Jofre.
